edotreotide has been researched along with bicalutamide in 1 studies
Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (bicalutamide) | Trials (bicalutamide) | Recent Studies (post-2010) (bicalutamide) |
---|---|---|---|---|---|
206 | 34 | 86 | 1,313 | 212 | 541 |
Protein | Taxonomy | edotreotide (IC50) | bicalutamide (IC50) |
---|---|---|---|
Progesterone receptor | Oryctolagus cuniculus (rabbit) | 5.6 | |
Progesterone receptor | Homo sapiens (human) | 1.819 | |
Androgen receptor | Homo sapiens (human) | 0.404 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.7168 | |
Androgen receptor | Mus musculus (house mouse) | 1.835 | |
Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.12 | |
Progesterone receptor | Rattus norvegicus (Norway rat) | 0.89 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Essler, M; Krause, BJ; Maurer, T; Souvatzoglou, M; Treiber, U; Weirich, G | 1 |
1 other study(ies) available for edotreotide and bicalutamide
Article | Year |
---|---|
68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases.
Topics: Anilides; Antineoplastic Agents; Cell Differentiation; Cisplatin; Etoposide; Humans; Male; Middle Aged; Nitriles; Octreotide; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Tosyl Compounds | 2009 |